GLP-1 agonists themselves contribute to improved metabolic health markers, such as better blood sugar control and potentially lower blood pressure and improved lipid profiles
Magnesium Magnesium deficiency worsens insulin resistance and oxidative stress
Citing limitations in the study, Novo Nordisk, which makes the drugs included in the claims analysis, said in a statement reported by Reuters that it does not believe these data are sufficient to draw conclusions about overall patient adherence and persistence to various GLP-1 medicines, including our treatments. Nonetheless, the problem of lack of patient persistence on GLP-1s under real-world conditions, examined and published by a growing number of sources, isnt going away
Recent research on the relationship between homocysteine, B12, and the risk for preeclampsia has shown mixed results
Oral semaglutide likewise resulted in reductions in weight during the trial